Refoxy Pharma is a pre-clinical stage biotechnology company developing medicines for the treatment and prevention of aging and aging-associated diseases. FOXO proteins are transcription factor proteins that bind to specific DNA sequences and thereby control (turn on/off) the expression of genes in those regions. This ability allows transcription factors to modulate different biological processes. Refoxy Pharma aims to harness the FOXO transcription factors to regulate the expression of multiple genes involved in processes like stress-resistance, metabolism, and longevity.